Live SpaceX Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about
Follow Scorpius Holdings, Inc.

Get SEC filing alerts via email and in your feed for Scorpius Holdings, Inc.

SCPX

Scorpius Holdings, Inc.

About Scorpius Holdings, Inc.

Scorpius Holdings, Inc. is a contract development and manufacturing organization (CDMO) specializing in biologics, cell- and gene-based therapies, and large molecule biologics. It offers process development, CGMP manufacturing, and quality control services primarily to biotech and pharma clients. The company operates a modern facility in Texas, supports U.S. government contracts, and emphasizes American-made equipment and domestic sourcing to enhance competitiveness.
This description was generated via AI from an annual report. Updated 9 months ago.

Latest SEC Filings from Scorpius Holdings, Inc.

1
1
Scorpius Holdings, Inc. Scorpius Holdings Reports Significant Revenue Decline and Operational Challenges

Via official filing (AI summary) | 4 months ago | 0 comments

2
1
Scorpius Holdings, Inc. Scorpius Holdings Reports Significant Revenue Decline and Financial Challenges in Latest 10-Q

Via official filing (AI summary) | 5 months ago | 0 comments

3
1
Scorpius Holdings, Inc. Scorpius Holdings Reports 94% Revenue Decline and $11.3 Million Net Loss in Q1 2025

Via official filing (AI summary) | 10 months ago | 0 comments

4
1
Scorpius Holdings, Inc. Scorpius Holdings Reports $34.3 Million Net Loss and Revenue Decline for Fiscal Year 2024

Via official filing (AI summary) | about 1 year ago | 0 comments